News
New Delhi: Torrent Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug ...
1d
GlobalData on MSNFDA free to pursue semaglutide compounders after latest court rulingDespite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final ...
Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...
3dOpinion
Montreal Gazette on MSNLabos: Ozempic’s oral counterpart hasn’t caught on yetThe prospect of a pill rather than an injection is obviously appealing to some people, but will fear of needles be enough to ...
Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...
Conduct CT in India: CDSCO Panel tells Novo Nordisk India For new formulation of Semaglutide tablets
The committee noted that semaglutide tablets 3 mg, 7 mg, and 14 mg are approved for marketing in India. The firm has claimed ...
Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...
As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...
7don MSN
Savvy pharma-stock investors know that an oral GLP-1 drug from Novo Nordisk called Rybelsus has been on the market as a ...
Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...
In an exclusive interview with NBC News' Stephanie Gosk, Eli Lilly's chief scientific officer says their weight loss pills ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results